Copyright Reports & Markets. All rights reserved.

Global Active Transdermal Drug Delivery Device Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Active Transdermal Drug Delivery Device Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Active Transdermal Drug Delivery Device Market Size Growth Rate by Product
      • 1.4.2 Patches
      • 1.4.3 Gels
    • 1.5 Market by End User
      • 1.5.1 Global Active Transdermal Drug Delivery Device Market Size Growth Rate by End User
      • 1.5.2 Clinic
      • 1.5.3 Hospital
      • 1.5.4 Home Use
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Active Transdermal Drug Delivery Device Market Size
      • 2.1.1 Global Active Transdermal Drug Delivery Device Revenue 2014-2025
      • 2.1.2 Global Active Transdermal Drug Delivery Device Sales 2014-2025
    • 2.2 Active Transdermal Drug Delivery Device Growth Rate by Regions
      • 2.2.1 Global Active Transdermal Drug Delivery Device Sales by Regions
      • 2.2.2 Global Active Transdermal Drug Delivery Device Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Active Transdermal Drug Delivery Device Sales by Manufacturers
      • 3.1.1 Active Transdermal Drug Delivery Device Sales by Manufacturers
      • 3.1.2 Active Transdermal Drug Delivery Device Sales Market Share by Manufacturers
      • 3.1.3 Global Active Transdermal Drug Delivery Device Market Concentration Ratio (CR5 and HHI)
    • 3.2 Active Transdermal Drug Delivery Device Revenue by Manufacturers
      • 3.2.1 Active Transdermal Drug Delivery Device Revenue by Manufacturers (2014-2019)
      • 3.2.2 Active Transdermal Drug Delivery Device Revenue Share by Manufacturers (2014-2019)
    • 3.3 Active Transdermal Drug Delivery Device Price by Manufacturers
    • 3.4 Active Transdermal Drug Delivery Device Manufacturing Base Distribution, Product Types
      • 3.4.1 Active Transdermal Drug Delivery Device Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Active Transdermal Drug Delivery Device Product Type
      • 3.4.3 Date of International Manufacturers Enter into Active Transdermal Drug Delivery Device Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Active Transdermal Drug Delivery Device Sales by Product
    • 4.2 Global Active Transdermal Drug Delivery Device Revenue by Product
    • 4.3 Active Transdermal Drug Delivery Device Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Active Transdermal Drug Delivery Device Breakdown Data by End User

    6 North America

    • 6.1 North America Active Transdermal Drug Delivery Device by Countries
      • 6.1.1 North America Active Transdermal Drug Delivery Device Sales by Countries
      • 6.1.2 North America Active Transdermal Drug Delivery Device Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Active Transdermal Drug Delivery Device by Product
    • 6.3 North America Active Transdermal Drug Delivery Device by End User

    7 Europe

    • 7.1 Europe Active Transdermal Drug Delivery Device by Countries
      • 7.1.1 Europe Active Transdermal Drug Delivery Device Sales by Countries
      • 7.1.2 Europe Active Transdermal Drug Delivery Device Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Active Transdermal Drug Delivery Device by Product
    • 7.3 Europe Active Transdermal Drug Delivery Device by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Active Transdermal Drug Delivery Device by Countries
      • 8.1.1 Asia Pacific Active Transdermal Drug Delivery Device Sales by Countries
      • 8.1.2 Asia Pacific Active Transdermal Drug Delivery Device Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Active Transdermal Drug Delivery Device by Product
    • 8.3 Asia Pacific Active Transdermal Drug Delivery Device by End User

    9 Central & South America

    • 9.1 Central & South America Active Transdermal Drug Delivery Device by Countries
      • 9.1.1 Central & South America Active Transdermal Drug Delivery Device Sales by Countries
      • 9.1.2 Central & South America Active Transdermal Drug Delivery Device Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Active Transdermal Drug Delivery Device by Product
    • 9.3 Central & South America Active Transdermal Drug Delivery Device by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Active Transdermal Drug Delivery Device by Countries
      • 10.1.1 Middle East and Africa Active Transdermal Drug Delivery Device Sales by Countries
      • 10.1.2 Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Active Transdermal Drug Delivery Device by Product
    • 10.3 Middle East and Africa Active Transdermal Drug Delivery Device by End User

    11 Company Profiles

    • 11.1 Novartis AG
      • 11.1.1 Novartis AG Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Novartis AG Active Transdermal Drug Delivery Device Products Offered
      • 11.1.5 Novartis AG Recent Development
    • 11.2 Noven Pharmaceuticals, Inc.
      • 11.2.1 Noven Pharmaceuticals, Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Products Offered
      • 11.2.5 Noven Pharmaceuticals, Inc. Recent Development
    • 11.3 Transdermal Corp.
      • 11.3.1 Transdermal Corp. Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Products Offered
      • 11.3.5 Transdermal Corp. Recent Development
    • 11.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
      • 11.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Products Offered
      • 11.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
    • 11.5 Mylan N.V.
      • 11.5.1 Mylan N.V. Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Products Offered
      • 11.5.5 Mylan N.V. Recent Development
    • 11.6 3M
      • 11.6.1 3M Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 3M Active Transdermal Drug Delivery Device Products Offered
      • 11.6.5 3M Recent Development
    • 11.7 Actavis, Inc.
      • 11.7.1 Actavis, Inc. Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Actavis, Inc. Active Transdermal Drug Delivery Device Products Offered
      • 11.7.5 Actavis, Inc. Recent Development
    • 11.8 Bayer AG
      • 11.8.1 Bayer AG Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Bayer AG Active Transdermal Drug Delivery Device Products Offered
      • 11.8.5 Bayer AG Recent Development
    • 11.9 Boehringer Ingelheim GmbH
      • 11.9.1 Boehringer Ingelheim GmbH Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Products Offered
      • 11.9.5 Boehringer Ingelheim GmbH Recent Development
    • 11.10 Corium International, Inc.
      • 11.10.1 Corium International, Inc. Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Products Offered
      • 11.10.5 Corium International, Inc. Recent Development
    • 11.11 Echo Therapeutics, Inc.
    • 11.12 GlaxoSmithKline plc

    12 Future Forecast

    • 12.1 Active Transdermal Drug Delivery Device Market Forecast by Regions
      • 12.1.1 Global Active Transdermal Drug Delivery Device Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Active Transdermal Drug Delivery Device Revenue Forecast by Regions 2019-2025
    • 12.2 Active Transdermal Drug Delivery Device Market Forecast by Product
      • 12.2.1 Global Active Transdermal Drug Delivery Device Sales Forecast by Product 2019-2025
      • 12.2.2 Global Active Transdermal Drug Delivery Device Revenue Forecast by Product 2019-2025
    • 12.3 Active Transdermal Drug Delivery Device Market Forecast by End User
    • 12.4 North America Active Transdermal Drug Delivery Device Forecast
    • 12.5 Europe Active Transdermal Drug Delivery Device Forecast
    • 12.6 Asia Pacific Active Transdermal Drug Delivery Device Forecast
    • 12.7 Central & South America Active Transdermal Drug Delivery Device Forecast
    • 12.8 Middle East and Africa Active Transdermal Drug Delivery Device Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Active Transdermal Drug Delivery Device Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Active Transdermal Drug Delivery Device market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Active Transdermal Drug Delivery Device market based on company, product type, end user and key regions.

      This report studies the global market size of Active Transdermal Drug Delivery Device in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Active Transdermal Drug Delivery Device in these regions.
      This research report categorizes the global Active Transdermal Drug Delivery Device market by top players/brands, region, type and end user. This report also studies the global Active Transdermal Drug Delivery Device market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Novartis AG
      Noven Pharmaceuticals, Inc.
      Transdermal Corp.
      Johnson & Johnson (Janssen Pharmaceuticals Inc.)
      Mylan N.V.
      3M
      Actavis, Inc.
      Bayer AG
      Boehringer Ingelheim GmbH
      Corium International, Inc.
      Echo Therapeutics, Inc.
      GlaxoSmithKline plc

      Market size by Product
      Patches
      Gels
      Market size by End User
      Clinic
      Hospital
      Home Use

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Active Transdermal Drug Delivery Device market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Active Transdermal Drug Delivery Device market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Active Transdermal Drug Delivery Device companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Active Transdermal Drug Delivery Device submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Active Transdermal Drug Delivery Device are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Active Transdermal Drug Delivery Device market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now